Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study

被引：5
|
作者：
Cruickshank, JM [1 ]
机构：
[1] Oxonian Cardiovasc Consultancy, Long Melford CO10 9DE, Suffolk, England
来源：
LANCET | 2002年 / 359卷 / 9324期
关键词：
D O I：
10.1016/S0140-6736(02)09071-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2200 / 2201
页数：2
相关论文
共 50 条
  • [31] The visceral adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes
    Mader, Arthur
    Saely, Christoph
    Vonbank, Doz. Alexander
    Heinzle, Christine
    Zanolin-Purin, Daniela
    Larcher, Barbara
    Leiherer, Andreas
    Muendlein, Doz Axel
    Drexel, Heinz
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 73 - 74
  • [32] The visceral adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Zanolin, D.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 293 - 293
  • [33] THE VISCERAL ADIPOSITY INDEX PREDICTS CARDIOVASCULAR EVENTS BOTH IN CARDIOVASCULAR DISEASE PATIENTS WITH AND IN THOSE WITHOUT DIABETES
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Purin, D.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E135 - E135
  • [34] Ten-year cardiovascular risk in diabetes patients without of coronary artery disease - a Danish cohort study
    Olesen, K. K. W.
    Madsen, M.
    Gyldenkerne, C.
    Thrane, P. G.
    Thim, T.
    Jensen, L. O.
    Botker, H. E.
    Sorensen, H. T.
    Maeng, M.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 3044 - 3044
  • [35] The Visceral Adiposity Index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Zanolin, D.
    Larcher, B.
    Mader, A.
    Ebner, K. -M.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 57 - 57
  • [36] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12): : 861 - 869
  • [37] Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study
    Fangel, Mia Vicki
    Nielsen, Peter Bronnum
    Kristensen, Jette Kolding
    Larsen, Torben Bjerregaard
    Overvad, Thure Filskov
    Lip, Gregory Y. H.
    Jensen, Martin Bach
    [J]. AMERICAN JOURNAL OF MEDICINE, 2020, 133 (06): : E269 - E279
  • [38] The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study
    Fossum, E
    Moan, A
    Kjeldsen, SE
    Devereux, RB
    Julius, S
    Snapinn, SM
    Edelman, JM
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Dahlöf, B
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) : 770 - 775
  • [39] ζ Association of Thyroid Function With Life Expectancy With and Without Cardiovascular Disease The Rotterdam Study
    Bano, Arjola
    Dhana, Klodian
    Chaker, Layal
    Kavousi, Maryam
    Ikram, M. Arfan
    Mattace-Raso, Francesco U. S.
    Peeters, Robin P.
    Franco, Oscar H.
    [J]. JAMA INTERNAL MEDICINE, 2017, 177 (11) : 1650 - 1657
  • [40] Cardiovascular risk in patients without known cardiovascular disease
    Carbone, R. G.
    Algahim, M. F.
    Rizzo, S.
    Monselise, A.
    Dart, R. A.
    Almassi, G. H.
    Gutterman, D. D.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (03) : 365 - 373
12345